Cutaneous Leishmaniasis: Updates in Diagnosis and Management

Area of Science:

• Infectious Diseases
• Parasitology
• Dermatology

Background:

• Cutaneous leishmaniasis (CL) is a diverse human disease caused by over 20 Leishmania species.
• Transmission occurs through the bite of infected sand flies.
• Accurate diagnosis and species identification are crucial for effective management.

Purpose of the Study:

• To highlight the complexity of treatment decisions for cutaneous leishmaniasis.
• To emphasize the need for individualized treatment strategies.
• To inform healthcare providers on factors influencing risk-benefit analyses for CL management.

Main Methods:

• Review of diagnostic recommendations for confirming CL and identifying Leishmania species.
• Analysis of factors influencing treatment decisions, including infecting species, comorbidities, lesion characteristics, and prior treatments.
• Consideration of disease self-healing potential and risk of metastatic complications like mucosal leishmaniasis.

Main Results:

• No single universal treatment exists for CL.
• Treatment can be associated with toxicity, necessitating careful consideration.
• Individualized risk-benefit assessments are essential for patient care.

Conclusions:

• Treatment for cutaneous leishmaniasis must be tailored to the individual patient.
• Factors such as infecting species, patient health, lesion details, and patient preferences are critical.
• Balancing treatment benefits against risks, including potential toxicity and metastatic spread, is paramount.